Abstract
Variation in cyclophosphamide pharmacokinetics and metabolism has been highlighted as a factor that may impact on clinical outcome in various tumour types. The current study in children with B-cell non-Hodgkin's lymphoma (NHL) was designed to corroborate previous findings in a large prospective study incorporating genotype for common polymorphisms known to influence cyclophosphamide pharmacology. A total of 644 plasma samples collected over a 5 year period, from 49 B-cell NHL patients ≤ 18 years receiving cyclophosphamide (250 mg/m(2)), were used to characterise a population pharmacokinetic model. Polymorphisms in genes including CYP2B6 and CYP2C19 were analysed. A two-compartment model provided the best fit of the population analysis. The mean cyclophosphamide clearance value following dose 1 was significantly lower than following dose 5 (1.83 ± 1.07 versus 3.68 ± 1.43 L/h/m(2), respectively; mean ± standard deviation from empirical Bayes estimates; P < 0.001). The presence of at least one CYP2B6*6 variant allele was associated with a lower cyclophosphamide clearance following both dose 1 (1.54 ± 0.11 L/h/m(2) versus 2.20 ± 0.31 L/h/m(2), P = 0.033) and dose 5 (3.12 ± 0.17 L/h/m(2) versus 4.35 ± 0.37 L/h/m(2), P = 0.0028), as ...Continue Reading
References
Nov 18, 1992·Journal of the National Cancer Institute·A V BoddyJ R Idle
Mar 1, 1991·Clinical Pharmacokinetics·M J Moore
Jan 1, 1988·Pharmacology & Therapeutics·N E Sladek
Jan 1, 1996·British Journal of Clinical Pharmacology·S M YuleJ R Idle
May 9, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A D R HuitemaS Rodenhuis
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·S Murray YuleAlan V Boddy
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William P PetrosJeffrey R Marks
May 8, 2010·Expert Opinion on Drug Metabolism & Toxicology·Bérénice GiraudAngelo Paci
Dec 24, 2010·British Journal of Clinical Pharmacology·Nuala A HelsbyMalcolm D Tingle
Apr 13, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Girish ChinnaswamyMichael Cole
Mar 3, 2012·British Journal of Clinical Pharmacology·Melanie S JoyRonald J Falk
Jun 28, 2014·Clinical Pharmacokinetics·Christopher R HillGareth J Veal
Jul 25, 2014·Cancer Chemotherapy and Pharmacology·David JamiesonAlan V Boddy
Citations
Sep 13, 2016·International Journal of Molecular Sciences·Vid MlakarMarc Ansari
Sep 20, 2016·Clinical Pharmacokinetics·Daphne BertholeeAndré B P van Kuilenburg
Apr 11, 2017·Drug Metabolism Reviews·Ivanna HrynchakVera Marisa Costa
Jan 14, 2017·Journal of Clinical Pharmacology·Francine Attié de CastroVera Lucia Lanchote
Oct 5, 2017·Pharmacogenomics·Konda KumaraswamiLiza Rajasekhar
Feb 9, 2019·Acta Ophthalmologica·Sanne E DetigerDion Paridaens
Jun 21, 2019·British Journal of Clinical Pharmacology·N A HelsbyK E Burns
Sep 5, 2019·Cancer Chemotherapy and Pharmacology·Inthuorn KulmaKesara Na-Bangchang
Aug 28, 2020·Frontiers in Pharmacology·Emma C BernsenLidwien M Hanff
May 15, 2018·Clinical Pharmacology and Therapeutics·Evan D Kharasch, Amanda Crafford
May 12, 2020·Frontiers in Pharmacology·Jemal Hussien AhmedEleni Aklillu
Jan 4, 2017·Expert Opinion on Pharmacotherapy·G Moroni, C Ponticelli
Jan 13, 2019·Biomolecules·Maria Pereira-OliveiraVera Marisa Costa
Dec 5, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Olivia CampagneClinton F Stewart
Mar 18, 2021·Medicine·Jin-Yu GongJian-Quan Luo
Apr 4, 2021·Pharmaceuticals·Shelby BarnettGareth J Veal
May 7, 2021·Frontiers in Pharmacology·Wendy Keung, Yiu-Fai Cheung
Apr 15, 2021·Molecular Cancer Therapeutics·Takaaki FujimuraYasushi Yoshimura
May 17, 2021·Life Sciences·Cho-Won Kim, Kyung-Chul Choi
May 28, 2021·Transplantation and Cellular Therapy·Takuto TakahashiPamala A Jacobson
Jun 12, 2021·Cancer Chemotherapy and Pharmacology·Nuala HelsbyDavid Porter
Jun 28, 2021·Pharmacology & Therapeutics·Daniele LavacchiStefania Nobili